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Integrated acoustic immunoaffinity-capture (IAI) platform for detection of PSA from 
whole blood samples. 
ABSTRACT 
On-chip detection of low abundant protein biomarkers is of interest to enable point-of-care 
diagnostics. Using a simple form of integration, we have realized an integrated microfluidic 
platform for the detection of prostate specific antigen (PSA), directly in anti-coagulated 
whole blood. We combine acoustophoresis-based separation of plasma from undiluted whole 
blood with a miniaturized immunoassay system in a polymer manifold, demonstrating 
improved assay speed on our Integrated Acoustic Immunoaffinity-capture (IAI) platform. 
The IAI platform separates plasma from undiluted whole blood by means of acoustophoresis 
and provides cell free plasma of clinical quality at a rate of 10 uL/min for an online 
immunoaffinity-capture of PSA on a porous silicon antibody microarray. The whole blood 
input (hematocrit 38-40%) rate was 50 μl min(-1) giving a plasma volume fraction yield of 
≈33%. PSA was immunoaffinity-captured directly from spiked female whole blood samples 
at clinically significant levels of 1.7-100 ng ml(-1) within 15 min and was subsequently 
detected via fluorescence readout, showing a linear response over the entire range with a 
coefficient of variation of 13%. 
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